Relaxation of FDA guidelines for human trial testing

Relaxation of FDA guidelines for human trial testing

Rapid evaluation and innovation requires a shotgun approach to developing multiple different drugs and trying them on active sick populations, of which there is no shortage. As long as rigorous and careful methodologies for data collection and analysis in these trials are maintained, the result of this approach will be more effective drugs, sooner -- which means thousands of saved lives by any calculus.


We need to develop anti-virals as quickly as possible to combat coronavirus. A slight relaxation of stringent guidelines would speed up the process and save lives. See Newsweek article:

Back to group

This content is created by the open source Your Priorities citizen engagement platform designed by the non profit Citizens Foundation

Your Priorities on GitHub

Check out the Citizens Foundation website for more information